FDA Inspection
Pfizer Asia Manufacturing Pte Ltd.Pfizer Asia Manufacturing Pte Ltd. – FDA Inspection, Mar 1, 2013
Record Details
This FDA Inspection record concerns Pfizer Asia Manufacturing Pte Ltd., with an inspection on March 1, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 1, 2013
- Product Type
- Drugs
View Company Profile
ID · 79a2f83e-dfb5-49c2-b8c0-ada3fd1e6753
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 825350
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Pfizer Asia Manufacturing Pte Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 27, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2019 | Not classified | Office of Inspections and Investigations | |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 19, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Pfizer Asia Manufacturing Pte Ltd.
- FDA Inspection 1156359 - 2021-10-27
- FDA Inspection 1085293 - 2019-03-15
- FDA Inspection 1009110 - 2017-03-24
- FDA Inspection 955761 - 2015-12-03
- FDA Inspection 580783 - 2009-03-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.